Class Action Lawsuit Filed Against Chemours for Misleading Investors on Product Demand and Financial Guidance.
16 hours ago
Schall, Brown & Schwartz LLP filed a class action lawsuit against Chemours, alleging misleading claims about Opteon product demand and 2026 financial guidance. Shareholders purchasing shares between February 20 and August 4, 2026, can join the suit by December 7 to seek recovery.